TRIM22 and esophageal squamous cell carcinoma: Lastly, while our findings indicate that Lyc.HCL exerts its anticancer effects through the modulation of TRIM22 and its downstream signaling pathways, the specific downstream mechanisms through which Lyc.HCL inhibits the cell cycle, metastasis, and invasion of ESCC remain to be fully elucidated.